Seoul, South Korea

Kyungmin Shin

This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Hk Inno.n Corporation. Active years: 2023.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Kyungmin Shin

Introduction

Kyungmin Shin is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative formulations. His work focuses on enhancing the stability and effectiveness of oral medications.

Latest Patents

Kyungmin Shin holds a patent for a preparation containing a benzimidazole derivative. This novel formulation comprises a compound of Formula 1 or a pharmaceutically acceptable salt thereof, along with at least one disintegrant selected from croscarmellose sodium, sodium starch glycolate, and low-substituted hydroxypropylcellulose. The formulation exhibits excellent storage stability and effectively prevents a decline in dissolution rate, making it a valuable option for oral administration.

Career Highlights

Kyungmin Shin is associated with Hk Inno.n Corporation, where he continues to develop innovative pharmaceutical solutions. His expertise in formulation science has positioned him as a key player in the industry.

Collaborations

He collaborates with talented coworkers, including Hyungsuk Lim and Chun Seon Lyu, to advance their research and development efforts.

Conclusion

Kyungmin Shin's contributions to pharmaceutical formulations demonstrate his commitment to innovation and improving medication efficacy. His work is paving the way for more effective treatments in the healthcare sector.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…